Esmya ulipristal acetate: Phase III started

Watson began a double-blind, U.S. Phase III trial to compare 10 mg Esmya plus iron vs. placebo plus iron in about 300 women with anemia associated with uterine fibroids who are planning a hysterectomy or myomectomy. ...